Why trash don't pass? pharmaceutical licensing and safety performance of drugs

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
Tannista Banerjee, Arnab Nayak

Abstract

This paper examines how asymmetric information in pharmaceutical licensing affects the safety standards of licensed drugs. Pharmaceutical companies often license potential drug molecules at different stages of drug development from other pharmaceutical or biotechnology companies and complete the remaining of research stages before submitting the new drug application(NDA) to the food and drug administration. The asymmetric information associated with the quality of licensed molecules might result in the molecules which are less likely to succeed to be licensed out, while those with greater potential of success being held internally for development. We identify the NDAs submitted between 1993 and 2004 where new molecular entities were acquired through licensing. Controlling for other drug area specific and applicant firm specific factors, we investigate whether drugs developed with licensed molecules face higher probability of safety based recall and ultimate withdrawal from the market than drugs developed internally. Results suggest the opposite of Akerlof's (Q J Econ 84:488-500, 1970) lemons problem. Licensed molecules rather have less probability of facing safety based recalls and ultimate withdrawal from the market comparing ...Continue Reading

References

May 1, 2002·JAMA : the Journal of the American Medical Association·Karen E LasserDavid H Bor
Jun 29, 2002·Nature Biotechnology·Dennis P Schafer
Nov 1, 2002·Nature Biotechnology·Katie ArnoldAlicia Löffler
Apr 14, 2004·Risk Analysis : an Official Publication of the Society for Risk Analysis·Thomas C Beierle
Feb 22, 2005·Journal of Health Economics·Patricia M DanzonNuno Sousa Pereira
Jan 13, 2006·The New England Journal of Medicine·Wayne A Ray, C Michael Stein
Mar 28, 2008·The New England Journal of Medicine·Daniel CarpenterJerry Avorn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.